Table 1 Base-line characteristics for all patients enrolled in the study
Characteristic | Azithromycin Group (n = 19) | Placebo Group (n = 16) | p-value |
|---|---|---|---|
Birth weight-g | 762 ± 94 | 736 ± 103 | NS |
Gestational age-wk | 25.6 ± 1.5 | 25.3 ± 1.0 | NS |
Male sex-no. (%) | 7 (36.8) | 8 (50) | NS |
Mother's racial group-no. (%) | Â | Â | Â |
Black | 1 (4.5) | 0 | NS |
White | 17 (89.5) | 16 (100) | Â |
Other | 1 (4.5) | 0 | Â |
Born at study hospital-no. (%) | 17 (89.5) | 13 (81.3) | NS |
Antenatal Steroids-no. (%) | 15 (78.9) | 12 (75) | NS |
Cesarean section-no. (%) | 17 (89.5) | 14 (87.5) | NS |
Apgar score at 1 minute | Â | Â | Â |
Median | 5 | 4 | NS |
Interquartile range | 2–6 | 1–7 |  |
Apgar score at 5 minute | Â | Â | Â |
Median | 7 | 7 | NS |
Interquartile range | 6–8 | 5–8 |  |
Initial mean airway pressure | 6.8 ± 1.3 | 6.6 ± 0.9 | NS |
Surfactant-no. of doses | 1.4 ± 0.7 | 1.8 ± 0.7 | NS |
Clinical history of chorioamnionitis-no. (%) | 1 (5.2) | 1 (6.2) | NS |